ELMOD3
ELMO domain-containing protein 3
Also known as: DFNB88, ELMD3_HUMAN, FLJ21977, RBED1, RBM29
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96FG2
- Gene
- ELMOD3
- Ensembl
- ENSG00000115459
- Chromosome
- 2
- Canonical length
- 381 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the engulfment and cell motility family of GTPase-activating proteins that regulate Arf GTPase proteins. Members of this family are defined by a conserved engulfment and cell motility domain. In rat cochlea, the encoded protein is found in stereocilia, kinocilia and cuticular plate of developing hair cells suggesting a function for this protein in cochlear sensory cells. An allelic variant of this family has been associated with autosomal recessive nonsyndromic deafness-88 in humans. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
381 residues, UniProt reviewed canonical sequence.
>Q96FG2|ELMOD3
1 MNEKSCSFHS KEELRDGQGE RLSAGYSPSY DKDKSVLAFR GIPISELKNH GILQALTTEA
61 YEWEPRVVST EVVRAQEEWE AVDTIQPETG SQASSEQPGQ LISFSEALQH FQTVDLSPFK
121 KRIQPTIRRT GLAALRHYLF GPPKLHQRLR EERDLVLTIA QCGLDSQDPV HGRVLQTIYK
181 KLTGSKFDCA LHGNHWEDLG FQGANPATDL RGAGFLALLH LLYLVMDSKT LPMAQEIFRL
241 SRHHIQQFPF CLMSVNITHI AIQALREECL SRECNRQQKV IPVVNSFYAA TFLHLAHVWR
301 TQRKTISDSG FVLKELEVLA KKSPRRLLKT LELYLARVSK GQASLLGAQK CYGPEAPPFK
361 DLTFTGESDL QSHSSEGVWL ILocalizationUniProt · AlphaFold · HPA
Whether an antibody against ELMOD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 11 nTPM
- adipose tissue: 11 nTPM
- tongue: 9.5 nTPM
- liver: 8.6 nTPM
- breast: 8.5 nTPM
- parathyroid gland: 8.4 nTPM
Single-cell type
- adipocytes: 580 nCPM
- myonuclei: 125 nCPM
- adrenal cortex cells: 95 nCPM
- oligodendrocytes: 72 nCPM
- sertoli cells: 72 nCPM
- leydig cells: 66 nCPM
Immune cell
- eosinophil: 8 nTPM
- basophil: 6.5 nTPM
- T-reg: 5.6 nTPM
- gdT-cell: 5.1 nTPM
- NK-cell: 5 nTPM
- naive CD8 T-cell: 4.8 nTPM
Brain region
- basal ganglia: 8.8 nTPM
- amygdala: 8.2 nTPM
- white matter: 8.1 nTPM
- cerebral cortex: 7.9 nTPM
- medulla oblongata: 7.9 nTPM
- midbrain: 7.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ELMOD3.
Disease | AllUniProt
Conditions ELMOD3 is implicated in, by any mechanism.
- Deafness, autosomal recessive, 88 (DFNB88) MIM:615429
- Deafness, autosomal dominant, 81 (DFNA81) MIM:619500
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 231 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Autosomal recessive nonsyndromic hearing loss 88
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.61
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.4
- DepMap mean gene effect
- -0.16
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- auditory receptor cell development
- cilium assembly
- cytoskeleton organization
- gene expression
- protein transport
- sensory perception of sound
- stereocilium maintenance
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ELMOD3 as an antibody target. Whether an autoantibody or antibody against ELMOD3 could matter depends on whether native ELMOD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ELMOD3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ELMOD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...